Regulations.gov document
Agency Response Letter from FDA CDER to Gland Pharma Limited
Other · FDA-2021-P-0923 · posted Dec 22, 2021
Key facts
| Document ID | FDA-2021-P-0923-0005 |
|---|---|
| Title | Agency Response Letter from FDA CDER to Gland Pharma Limited |
| Document type | Other |
| Subtype | Agency Response |
| Agency | FDA |
| Docket | FDA-2021-P-0923 |
| Posted | Dec 22, 2021 |
| Comment period opens | Dec 22, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: